Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST)
An open label, randomized controlled trial comparing single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire
Lecture about schistosomiasis diagnostics
On October 25th 2021, Lisette van Lieshout gave an online international seminar about schistosomiasis diagnostic research at the LUMC. This presentation gives an up-to-date overview of the non-microscopy diagnostic assays the group is working on, with a focus on the detection of the circulating antigens CCA and CAA.
The full recording can be seen here. The pdf of the slides are available here.
First results published!
Impression of the field work
RePST is an open-label, randomised controlled trial which has been conducted in school-aged children (5 to 18 years) from the region of Taabo, Côte d’Ivoire, an area endemic for Schistosoma mansoni.